Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 1,067.16 million compared to CNY 788.26 million a year ago. Revenue was CNY 1,080.05 million compared to CNY 799.68 million a year ago.

Net income was CNY 61.65 million compared to CNY 38.79 million a year ago. Basic earnings per share from continuing operations was CNY 0.2032 compared to CNY 0.1279 a year ago. Diluted earnings per share from continuing operations was CNY 0.2032 compared to CNY 0.1279 a year ago.